To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MRPL44TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
303 supporting clones for gene MRPL44 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB032262 testis .a 1 to 594 2 to 595   tiling clone, capped   594/594
(100 %)
0 diff
(100 %id)
CD690651 normal nasopharynx .a 20 to 652 19 to 649       631/649
(97 %)
7 diff
(99.0 %id)
CD702660 normal nasopharynx .a 20 to 545 13 to 539       527/539
(97 %)
11 diff
(98.0 %id)
AL703412 human skeletal muscle .a 20 to 553 1 to 531       531/531
(100 %)
11 diff
(98.0 %id)
NM_022915.3   .a 20 to 1765 1 to 1746 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1746/1746
(100 %)
1 diff
(100.0 %id)
BG699238 brain, hippocampus .a 21 to 805 1 to 789       789/790
(99 %)
12 diff
(98.5 %id)
BG699445 brain, hippocampus .a 21 to 819 1 to 796       796/796
(100 %)
13 diff
(98.4 %id)
DA936831 Spleen .a 25 to 607 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DB469551 hippocampus .a 26 to 457 1 to 432       432/432
(100 %)
0 diff
(100 %id)
DA675358   .a 27 to 616 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA905898   .a 27 to 584 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BP261975 small intestine .a 28 to 611 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BI462668 testis .a 28 to 781 1 to 762       762/951
(80 %)
16 diff
(98.4 %id)
BI464770 testis .a 28 to 532 1 to 506       506/506
(100 %)
6 diff
(98.9 %id)
DA376490 thalamus .a 29 to 587 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA621287 Kidney .a 29 to 600 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA890103 rectum .a 29 to 597 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB067016 testis .a 29 to 613 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
BU665159 blood .a 35 to 712 10 to 687       678/687
(98 %)
6 diff
(99.2 %id)
DA276126 corpus callosum .a 36 to 606 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BP273046   .a 41 to 602 1 to 562       562/562
(100 %)
8 diff
(98.6 %id)
AU280614   .a 41 to 608 1 to 568       568/568
(100 %)
0 diff
(100 %id)
DA565980 heart .a 42 to 608 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA891895 rectum .a 42 to 598 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BG704268 brain, hippocampus .a 45 to 876 1 to 833       833/833
(100 %)
27 diff
(96.8 %id)
BP257266 heart .a 49 to 608 1 to 560       560/562
(99 %)
16 diff
(97.2 %id)
DA605497   .a 50 to 598 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB113696 thymus .a 51 to 617 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DT218574 brain .a 52 to 665 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BM149945 leukopheresis .a 52 to 368 1 to 317       317/317
(100 %)
11 diff
(96.6 %id)
BM194502 leukopheresis .a 52 to 567 1 to 516       516/518
(99 %)
2 diff
(99.7 %id)
DA076699 cerebellum .a 53 to 636 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA605022   .a 54 to 594 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB010958 colon, tumor tissue .a 54 to 611 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BP203711 coronary artery .a 58 to 641 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BP262033 small intestine .a 58 to 633 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BP198413 adrenal gland .a 59 to 646 1 to 588       588/588
(100 %)
0 diff
(100 %id)
CB117672 brain .a 59 to 353 1 to 295       295/295
(100 %)
4 diff
(98.7 %id)
BP209395 cerebellum .a 59 to 640 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP225472   .a 59 to 639 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB489478 hypothalamus .a 59 to 537 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
DA430690 colon .a 60 to 638 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CX872897 embryonic stem .a 65 to 901 5 to 841       837/841
(99 %)
8 diff
(99.1 %id)
DA696048   .a 65 to 638 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BP262352 small intestine .a 66 to 648 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BG714892 brain, hypothalamus .a 66 to 915 1 to 854       854/862
(99 %)
17 diff
(98.1 %id)
BG715477 brain, hypothalamus .a 66 to 798 1 to 739       739/743
(99 %)
17 diff
(97.8 %id)
BG697733 skin .a 66 to 784 1 to 721       721/842
(85 %)
5 diff
(99.5 %id)
BI560672 testis .a 66 to 899 1 to 840       840/903
(93 %)
35 diff
(96.2 %id)
DA349481 substantia nigra .a 67 to 618 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB491665 hypothalamus .a 67 to 506 1 to 431       431/431
(100 %)
35 diff
(91.9 %id)
C03423 heart .a 70 to 329 1 to 264       264/264
(100 %)
8 diff
(97.0 %id)
BP195961 brain .a 71 to 652 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AK022763   .a 71 to 1760 1 to 1690 exact available from FLJ,   1690/1690
(100 %)
6 diff
(99.7 %id)
BF172655 blood .a 71 to 378 1 to 303       303/303
(100 %)
10 diff
(96.7 %id)
AL695384   .a 71 to 599 10 to 539       530/530
(100 %)
1 diff
(99.9 %id)
DA512440 brain .a 71 to 612 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA520048 brain .a 71 to 644 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BI755220 brain .a 71 to 801 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
BI753921 brain .a 71 to 740 1 to 683       683/771
(88 %)
25 diff
(96.8 %id)
BI758569 brain .a 71 to 800 28 to 764       737/764
(96 %)
17 diff
(97.8 %id)
TI_57215612   .a 71 to 819 35 to 801       767/805
(95 %)
21 diff
(97.4 %id)
TI_57215823   .a 71 to 801 28 to 758       731/758
(96 %)
6 diff
(99.3 %id)
TI_57215824   .a 71 to 800 28 to 764       737/764
(96 %)
17 diff
(97.8 %id)
TI_44349662   .a 71 to 899 89 to 923   AAA   835/978
(85 %)
36 diff
(96.4 %id)
CB118273 Liver .a 71 to 715 1 to 645       645/645
(100 %)
0 diff
(100 %id)
DA695844   .a 71 to 642 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM837167 Ascites, stomach .a 71 to 633 9 to 571       563/571
(98 %)
8 diff
(98.6 %id)
DA370790 thalamus .a 72 to 633 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA561091 heart .a 72 to 629 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BE788310 large cell carcinoma, lung .a 72 to 737 1 to 666       666/881
(75 %)
11 diff
(98.8 %id)
BF699146 brain, primitive neuroectoderm .a 72 to 691 1 to 625       625/1023
(61 %)
17 diff
(98.4 %id)
DA686113   .a 72 to 387 2 to 317   capped   316/316
(100 %)
0 diff
(100 %id)
DA729217   .a 72 to 860 2 to 785   capped   784/791
(99 %)
13 diff
(98.4 %id)
AU126380   .a 72 to 859 2 to 803   capped   802/826
(97 %)
29 diff
(96.5 %id)
DA764282 tongue .a 72 to 646 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BG338104 leiomyosarcoma cell line, uterus .a 73 to 613 1 to 543       543/543
(100 %)
3 diff
(99.5 %id)
BC012058 Uterus, leiomyosarcoma .a 74 to 1240 1 to 1167 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1167/1167
(100 %)
1 diff
(100.0 %id)
BX421883 T cells (Jurkat cell line) .a 74 to 1125 1 to 1047 L50X L51S R52A C53V P55A ...     1047/1047
(100 %)
16 diff
(98.5 %id)
DB451676 testis .a 74 to 567 1 to 494       494/494
(100 %)
0 diff
(100 %id)
DB452398 testis .a 74 to 550 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
DB462813 hippocampus .a 74 to 541 1 to 468       468/468
(100 %)
6 diff
(98.8 %id)
DB476178 hippocampus .a 74 to 549 1 to 476       476/476
(100 %)
2 diff
(99.6 %id)
DB476403 hippocampus .a 74 to 557 1 to 484       484/484
(100 %)
2 diff
(99.6 %id)
DB506493 hypothalamus .a 74 to 548 1 to 475       475/475
(100 %)
0 diff
(100 %id)
BP258558 heart .a 74 to 582 1 to 509       509/581
(87 %)
10 diff
(98.3 %id)
BG697501 skin .a 74 to 803 1 to 728       728/728
(100 %)
5 diff
(99.4 %id)
CB996554 placenta, pre-eclamptic placenta .a 74 to 737 28 to 694       667/860
(77 %)
19 diff
(97.8 %id)
CB997613 placenta, pre-eclamptic placenta .a 74 to 596 28 to 558       531/937
(56 %)
37 diff
(96.1 %id)
DB256190 uterus .a 74 to 647 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA001522   .a 75 to 292 2 to 219   capped   218/218
(100 %)
0 diff
(100 %id)
DA361645 subthalamic nucleus .a 75 to 631 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BP215144 corpus callosum .a 75 to 656 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CD387150 embryonic trophoblasts, made from WA01 stemcells .a 75 to 740 24 to 692       669/944
(70 %)
17 diff
(98.2 %id)
BU557254 ovary, teratocarcinoma, cell line .a 75 to 888 1 to 819       819/870
(94 %)
11 diff
(98.8 %id)
DA607351   .a 75 to 619 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA616332   .a 75 to 654 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DB142063 thymus .a 75 to 619 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA560970 heart .a 76 to 608 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
BU602908 mixed (pool of 40 RNAs) .a 76 to 816 1 to 744       744/823
(90 %)
25 diff
(97.0 %id)
BP195792 brain .a 77 to 660 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
DA143078 alzheimer cortex .a 77 to 645 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BE243883 leukopheresis .a 77 to 361 1 to 285       285/285
(100 %)
7 diff
(97.6 %id)
DB045103 testis .a 77 to 641 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AK024052   .a 78 to 1760 1 to 1685 W232R available from FLJ,   1685/1685
(100 %)
10 diff
(99.5 %id)
CD694413 normal nasopharynx .a 79 to 628 33 to 583       551/583
(94 %)
9 diff
(98.5 %id)
DA431916 colon .a 79 to 652 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
CB143246 Liver .a 79 to 696 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
DB246992   .a 79 to 638 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AU143540   .a 79 to 853 2 to 779   capped   778/811
(95 %)
9 diff
(98.9 %id)
CR598480 Placenta Cot 25-normalized .a 80 to 1729 1 to 1650 exact     1650/1650
(100 %)
0 diff
(100 %id)
BQ421029 embryonal carcinoma, cell line, testis .a 83 to 1172 14 to 1095 K246X K247E S255I D277G K278*     1080/1098
(98 %)
41 diff
(96.3 %id)
BP209149 cerebellum .a 84 to 641 1 to 558       558/577
(96 %)
5 diff
(99.2 %id)
T27099   .a 84 to 479 1 to 396       396/396
(100 %)
5 diff
(98.8 %id)
BP310316 brain .a 84 to 666 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP320729 placenta .a 84 to 666 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA055106 cerebellum .a 85 to 637 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA064962 cerebellum .a 85 to 653 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA284356 corpus callosum .a 85 to 566 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DA357049 subthalamic nucleus .a 85 to 636 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
TI_1948153628   .a 85 to 564 123 to 602   fully sequenced,   480/602
(79 %)
12 diff
(98.1 %id)
TI_1948153768   .a 85 to 532 124 to 573   fully sequenced,   450/573
(78 %)
8 diff
(98.7 %id)
DA900258 skeletal muscle .a 85 to 639 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB020762 testis .a 85 to 618 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DB043425 testis .a 85 to 557 2 to 476   capped   475/475
(100 %)
2 diff
(99.6 %id)
R13502 whole brain .a 86 to 439 1 to 354       354/354
(100 %)
5 diff
(98.6 %id)
R55686 whole brain .a 86 to 582 1 to 505     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 505/506
(99 %)
23 diff
(95.5 %id)
CX754324 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 86 to 859 1 to 771     Submitted on the opposite strand 771/771
(100 %)
9 diff
(98.9 %id)
CR619403 fetal brain .a 87 to 1730 1 to 1644 exact     1644/1644
(100 %)
0 diff
(100 %id)
BX418552 brain, fetal brain .a 87 to 998 1 to 907   fully sequenced,   907/907
(100 %)
7 diff
(99.3 %id)
CR457293   .a 89 to 1086 1 to 998       998/999
(99 %)
2 diff
(99.8 %id)
BX460187 brain, fetal brain .a 89 to 1017 1 to 916       918/956
(96 %)
18 diff
(98.2 %id)
BX098662 heart .a 90 to 841 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BX378921 Placenta Cot 25-normalized .a 90 to 915 10 to 837       828/1029
(80 %)
7 diff
(99.4 %id)
W79626 heart .a 90 to 573 1 to 487       487/488
(99 %)
10 diff
(98.0 %id)
BM477275 lymph, lymphoma, cell line .a 92 to 1124 1 to 1031       1031/1088
(94 %)
19 diff
(98.3 %id)
BM924516 pooled colon, kidney, stomach .a 92 to 979 1 to 896       894/1086
(82 %)
25 diff
(97.7 %id)
CV815884 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 92 to 937 1 to 856       856/892
(95 %)
34 diff
(96.2 %id)
CX753258 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 92 to 788 1 to 697     Submitted on the opposite strand 697/697
(100 %)
2 diff
(99.8 %id)
CR613852 Placenta Cot 25-normalized .a 93 to 1713 1 to 1621       1621/1621
(100 %)
0 diff
(100 %id)
AL545110 placenta, Placenta Cot 25-normalized .a 93 to 946 1 to 857   fully sequenced,   857/857
(100 %)
3 diff
(99.7 %id)
BU192453 large cell carcinoma, lung .a 93 to 870 1 to 785       785/825
(95 %)
16 diff
(98.1 %id)
BQ226575 melanotic melanoma, skin .a 93 to 925 1 to 838       838/890
(94 %)
14 diff
(98.5 %id)
BQ221270 large cell carcinoma, lung .a 93 to 587 1 to 497       497/1027
(48 %)
23 diff
(97.8 %id)
CN310455 embryonic stem cells, cell lines H1, H7, andH9 .a 94 to 766 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
CN310456 embryonic stem cells, cell lines H1, H7, andH9 .a 95 to 779 1 to 686       686/686
(100 %)
5 diff
(99.3 %id)
BG035417 adenocarcinoma, cell line, Liver .a 95 to 892 1 to 797       797/1075
(74 %)
22 diff
(98.0 %id)
AL514362 neuroblastoma, placenta .a 97 to 994 1 to 904   fully sequenced,   904/904
(100 %)
11 diff
(98.8 %id)
CN310458 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 97 to 760 13 to 676       664/676
(98 %)
9 diff
(98.7 %id)
CR626643 neuroblastoma .a 97 to 1759 1 to 1663   tiling clone,   1663/1663
(100 %)
0 diff
(100 %id)
BM547681 brain, hippocampus .a 97 to 907 1 to 816       816/1142
(71 %)
12 diff
(99.0 %id)
N46128 melanocyte .a 98 to 470 1 to 373     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 373/376
(99 %)
10 diff
(97.4 %id)
AW249380 lung, small cell carcinoma .a 99 to 700 1 to 602       602/602
(100 %)
6 diff
(99.1 %id)
BG765535 melanotic melanoma, high MDR (cell line), skin .a 103 to 915 1 to 823       823/886
(92 %)
21 diff
(97.7 %id)
W90044 liver and spleen .a 105 to 611 1 to 505       505/505
(100 %)
3 diff
(99.5 %id)
CN310457 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 108 to 550 13 to 455       443/455
(97 %)
6 diff
(98.7 %id)
CN310460 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 108 to 705 9 to 607       599/607
(98 %)
7 diff
(98.9 %id)
BU155322 melanotic melanoma, skin .a 111 to 946 1 to 850       850/902
(94 %)
18 diff
(98.1 %id)
CN310462 embryonic stem cells, DMSO-treated H9 cellline .a 112 to 615 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BE536878 cervix .a 113 to 762 1 to 665       665/667
(99 %)
16 diff
(97.7 %id)
BG036197 adenocarcinoma, cell line, Prostate .a 113 to 881 1 to 767       767/957
(80 %)
14 diff
(98.6 %id)
CN310459 embryonic stem cells, cell lines H1, H7, andH9 .a 119 to 579 1 to 461       461/461
(100 %)
0 diff
(100 %id)
CN310454 embryonic stem cells, DMSO-treated H9 cellline .a 122 to 761 1 to 640       640/640
(100 %)
0 diff
(100 %id)
W40494 Pancreas, pancreatic islet .a 125 to 477 1 to 357     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 357/357
(100 %)
9 diff
(97.5 %id)
BE264998 lung, small cell carcinoma .a 128 to 804 1 to 678       678/678
(100 %)
7 diff
(99.0 %id)
CN310463 embryonic stem cells, cell lines H1, H7, andH9 .a 129 to 814 1 to 686       686/686
(100 %)
0 diff
(100 %id)
CX754000 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 136 to 848 1 to 710     Submitted on the opposite strand 710/710
(100 %)
6 diff
(99.2 %id)
AA081640   .a 192 to 521 1 to 332       332/332
(100 %)
9 diff
(97.3 %id)
TI_1948153511   .a 300 to 1089 918 to 121       798/1369
(58 %)
36 diff
(97.4 %id)
TI_149310468   .a 307 to 1235 1007 to 89   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 919/961
(95 %)
19 diff
(98.1 %id)
BU186224 large cell carcinoma, lung .a 319 to 1180 1 to 864       864/865
(99 %)
8 diff
(99.1 %id)
BM462885 melanotic melanoma, skin .a 328 to 833 46 to 551       506/1114
(45 %)
19 diff
(98.3 %id)
DA224629 brain .a 344 to 868 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
CN310464 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 375 to 931 18 to 574       557/574
(97 %)
5 diff
(99.2 %id)
BQ961422 leiomyosarcoma, uterus .a 396 to 1263 1 to 877       877/883
(99 %)
14 diff
(98.5 %id)
BM795924 Ascites, stomach .a 405 to 928 1 to 524       524/524
(100 %)
1 diff
(99.9 %id)
DR156688 human embryonic stem cells differentiated toan early endodermal cell type .a 416 to 1102 1 to 687       687/687
(100 %)
0 diff
(100 %id)
BG031637 breast, mammary adenocarcinoma, cell line .a 421 to 1148 1 to 724       724/912
(79 %)
8 diff
(99.2 %id)
W87443 liver and spleen .a 443 to 847 1 to 406       406/406
(100 %)
6 diff
(98.6 %id)
BI255145 cervical carcinoma cell line, cervix .a 443 to 1222 1 to 775       775/781
(99 %)
8 diff
(99.0 %id)
AI338045 uterus .a 475 to 1241 753 to 2       752/853
(88 %)
28 diff
(96.8 %id)
BE742742 adenocarcinoma cell line, ovary .a 492 to 1195 1 to 701       701/978
(71 %)
18 diff
(98.2 %id)
TI_1948153769   .a 502 to 1089 698 to 107   fully sequenced,   592/698
(84 %)
7 diff
(99.0 %id)
BQ014196 Chondrosarcoma, Left Pubic Bone .a 511 to 1240 749 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 731/731
(100 %)
4 diff
(99.5 %id)
BQ014213 Chondrosarcoma, Left Pubic Bone .a 512 to 1235 743 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 725/725
(100 %)
2 diff
(99.8 %id)
BU688764 lung .a 514 to 1235 739 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 721/721
(100 %)
2 diff
(99.8 %id)
AA136405 lung, lung carcinoma .a 527 to 913 1 to 387     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
CF134944 CNCAP(3)T-225 cell line, Prostate .a 534 to 1002 1 to 469       469/470
(99 %)
9 diff
(98.1 %id)
TI_1948153629   .a 534 to 1089 668 to 109   fully sequenced,   560/668
(83 %)
10 diff
(98.6 %id)
TI_154163074   .a 541 to 1258 80 to 795       716/717
(99 %)
37 diff
(94.9 %id)
BE769551 prostate_tumor .a 567 to 915 350 to 2       349/350
(99 %)
2 diff
(99.5 %id)
CA423714 cell lines, Chondrosarcoma .a 577 to 1240 682 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 664/664
(100 %)
2 diff
(99.7 %id)
BG028827 Bone, osteosarcoma, cell line .a 591 to 1335 1 to 743       743/843
(88 %)
37 diff
(95.7 %id)
BF111644 pooled .a 602 to 1240 651 to 13   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 639/639
(100 %)
5 diff
(99.3 %id)
BE467972 carcinoid, lung .a 608 to 1239 632 to 1       632/632
(100 %)
5 diff
(99.3 %id)
BE328861 carcinoid, lung .a 614 to 1239 626 to 1       626/626
(100 %)
5 diff
(99.3 %id)
BE702225 nervous_normal .a 628 to 999 375 to 5       371/375
(98 %)
0 diff
(100 %id)
BF372424 prostate_tumor .a 631 to 915 308 to 19       290/308
(94 %)
5 diff
(98.4 %id)
CA431571 cell lines, Enchondroma .a 638 to 1240 621 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 603/603
(100 %)
1 diff
(99.9 %id)
N26338 melanocyte .a 666 to 1140 1 to 475       475/476
(99 %)
2 diff
(99.6 %id)
BE669441 carcinoid, lung .a 677 to 1241 567 to 3       565/567
(99 %)
0 diff
(100 %id)
BM753284 Ascites, stomach .a 680 to 1130 1 to 451       451/451
(100 %)
2 diff
(99.6 %id)
CN310461 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 683 to 1430 9 to 756       748/756
(98 %)
1 diff
(99.9 %id)
BE539500 cervix .a 701 to 1421 1 to 731       731/796
(91 %)
45 diff
(94.4 %id)
AI186810 lung .a 713 to 915 208 to 6       202/208
(97 %)
0 diff
(100 %id)
BF507898   .a 713 to 1229 544 to 28   AAA   517/527
(98 %)
1 diff
(99.9 %id)
BE348564 carcinoid, lung .a 713 to 1239 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
CB123298 Liver .a 714 to 1237 524 to 1     Submitted on the opposite strand 524/524
(100 %)
2 diff
(99.7 %id)
R20623 whole brain .a 720 to 1231 549 to 37   AAA   513/522
(98 %)
7 diff
(98.7 %id)
W90000.
matches multiple genes
liver and spleen .a 744 to 1237 481 to 1     also hits gene spoybeebu 481/483
(99 %)
21 diff
(95.7 %id)
CA310419 cell lines, Chondrosarcoma .a 748 to 1240 511 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 493/493
(100 %)
1 diff
(99.8 %id)
CD368303 Alveolar Macrophage, lung .a 749 to 1240 511 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 493/493
(100 %)
2 diff
(99.6 %id)
BF194842 Kidney .a 753 to 1241 489 to 1       489/493
(99 %)
16 diff
(96.8 %id)
BQ018665 lung, Metastatic Chondrosarcoma .a 760 to 1240 500 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 482/491
(98 %)
2 diff
(99.6 %id)
W79482 heart .a 764 to 1241 481 to 2       480/481
(99 %)
3 diff
(99.4 %id)
AA931694 carcinoid, lung .a 793 to 1239 447 to 1       447/447
(100 %)
3 diff
(99.4 %id)
BG169663 hypernephroma, cell line, Kidney .a 793 to 1508 1 to 692       692/924
(74 %)
31 diff
(96.7 %id)
DB537142 hippocampus .a 798 to 1235 1 to 438     Submitted on the opposite strand 438/438
(100 %)
1 diff
(99.8 %id)
AW136308   .a 799 to 1240 459 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 442/442
(100 %)
2 diff
(99.6 %id)
AA478905 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 820 to 1236 10 to 426   fully sequenced, Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 417/426
(97 %)
8 diff
(98.2 %id)
FN048986 breast carcinoma .a 826 to 931 108 to 1     Submitted on the opposite strand 108/108
(100 %)
2 diff
(98.2 %id)
R55687 whole brain .a 828 to 1240 447 to 27   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 421/421
(100 %)
19 diff
(95.5 %id)
AW058071 thymus, pooled .a 828 to 1239 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
BQ345553 nervous_tumor .a 838 to 1404 1 to 561       561/561
(100 %)
27 diff
(95.2 %id)
AW182353 pooled .a 854 to 1241 391 to 4       388/391
(99 %)
0 diff
(100 %id)
W87306 liver and spleen .a 875 to 1246 372 to 1       372/372
(100 %)
6 diff
(98.4 %id)
AA703389 liver and spleen .a 881 to 1241 363 to 1       363/363
(100 %)
5 diff
(98.7 %id)
AL570970 placenta, Placenta Cot 25-normalized .a 885 to 1705 838 to 11   fully sequenced,   828/838
(98 %)
0 diff
(100 %id)
AI767123 2 pooled tumors (clear cell type), Kidney .a 885 to 1243 362 to 4       359/362
(99 %)
0 diff
(100 %id)
AI277412 placenta .a 890 to 1246 369 to 13   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 357/357
(100 %)
1 diff
(99.8 %id)
AI282660 esophagus, squamous cell carcinoma .a 891 to 1240 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AA478787 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 898 to 1240 369 to 27   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 343/343
(100 %)
1 diff
(99.8 %id)
CA440538 lung, Lung Focal Fibrosis .a 905 to 1199 14 to 308     Submitted on the opposite strand 295/304
(97 %)
1 diff
(99.7 %id)
CN480462 lung, Lung Focal Fibrosis .a 905 to 1199 14 to 309     Submitted on the opposite strand 296/305
(97 %)
6 diff
(98.1 %id)
BX378920 Placenta Cot 25-normalized .a 908 to 1729 828 to 1       828/1075
(77 %)
11 diff
(99.0 %id)
W90244 liver and spleen .a 910 to 1231 328 to 1       328/331
(99 %)
13 diff
(96.1 %id)
AA136215 lung, lung carcinoma .a 912 to 1240 357 to 29   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 329/420
(78 %)
7 diff
(98.4 %id)
AI193958 lung .a 918 to 1239 322 to 1       322/322
(100 %)
1 diff
(99.7 %id)
BE774695 uterus .a 927 to 1217 300 to 10       291/322
(90 %)
0 diff
(100 %id)
AA663371   .a 939 to 1126 188 to 1       188/188
(100 %)
1 diff
(99.5 %id)
AW795733 uterus .a 942 to 1234 1 to 291       291/291
(100 %)
5 diff
(98.3 %id)
T97614 liver and spleen .a 943 to 1233 297 to 7       291/297
(97 %)
0 diff
(100 %id)
BG286011 bladder, transitional cell papilloma, cell line .a 946 to 1695 1 to 735       735/931
(78 %)
33 diff
(96.5 %id)
BG025298 lymph, lymphoma, cell line .a 955 to 1560 13 to 631       619/632
(97 %)
27 diff
(95.8 %id)
BE076698 breast .a 963 to 1225 264 to 2     Submitted on the opposite strand 263/264
(99 %)
0 diff
(100 %id)
AL514361 neuroblastoma, placenta .a 964 to 1759 794 to 1   fully sequenced,   794/794
(100 %)
27 diff
(96.6 %id)
AA657536   .a 967 to 1281 1 to 316       316/316
(100 %)
5 diff
(98.5 %id)
BX454792 brain, fetal brain .a 968 to 1730 767 to 1   fully sequenced,   767/767
(100 %)
23 diff
(97.1 %id)
CB118092 Liver .a 969 to 1237 270 to 1     Submitted on the opposite strand 270/270
(100 %)
6 diff
(97.8 %id)
AW974934   .a 973 to 1481 111 to 623       513/623
(82 %)
6 diff
(99.1 %id)
CD693658 normal nasopharynx .a 996 to 1643 22 to 666       645/666
(96 %)
6 diff
(99.1 %id)
BM547354 ovary (pool of 3) .a 1012 to 1758 14 to 761       748/1114
(67 %)
41 diff
(96.4 %id)
T27098   .a 1015 to 1240 226 to 1       226/230
(98 %)
1 diff
(99.6 %id)
N31234 melanocyte .a 1048 to 1443 1 to 396   fully sequenced,   396/396
(100 %)
1 diff
(99.8 %id)
N36858 melanocyte .a 1063 to 1240 193 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 177/177
(100 %)
2 diff
(98.9 %id)
BQ301280 bocio_tumor .a 1086 to 1343 260 to 1       260/260
(100 %)
13 diff
(95.0 %id)
AI193351 lung .a 1088 to 1238 156 to 6       151/156
(96 %)
0 diff
(100 %id)
BQ301184 bocio_tumor .a 1099 to 1343 245 to 1       245/246
(99 %)
5 diff
(98.0 %id)
CB132022 Liver .a 1136 to 1767 1 to 633       633/649
(97 %)
7 diff
(99.0 %id)
DB354249   .a 1169 to 1760 587 to 1       587/587
(100 %)
20 diff
(96.6 %id)
AU160615   .a 1199 to 1760 560 to 1       560/561
(99 %)
21 diff
(96.3 %id)
TI_154161265   .a 1219 to 1758 634 to 95   AAA Submitted on the opposite strand 540/542
(99 %)
0 diff
(100 %id)
DB544976 hippocampus .a 1263 to 1758 1 to 496     Submitted on the opposite strand 496/497
(99 %)
5 diff
(99.0 %id)
AW190925 adenocarcinoma, Pancreas .a 1263 to 1766 503 to 1       503/503
(100 %)
3 diff
(99.5 %id)
AI936229 normal prostate, Prostate .a 1265 to 1767 506 to 3       504/506
(99 %)
0 diff
(100 %id)
AI983530 brain, three pooled meningiomas .a 1281 to 1760 482 to 1       482/482
(100 %)
7 diff
(98.6 %id)
AA992562   .a 1296 to 1767 472 to 2       471/472
(99 %)
0 diff
(100 %id)
DB545159 hippocampus .a 1299 to 1758 1 to 460     Submitted on the opposite strand 460/461
(99 %)
1 diff
(99.8 %id)
BI324965 Pancreas, Purified pancreatic islet .a 1300 to 1766 468 to 1       468/468
(100 %)
4 diff
(99.2 %id)
DB559012 hypothalamus .a 1306 to 1758 1 to 454     Submitted on the opposite strand 454/454
(100 %)
2 diff
(99.6 %id)
DB517161 testis .a 1307 to 1763 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
H99222 melanocyte .a 1309 to 1759 462 to 7       456/462
(98 %)
0 diff
(100 %id)
DB528372 hippocampus .a 1310 to 1758 1 to 449     Submitted on the opposite strand 449/450
(99 %)
3 diff
(99.4 %id)
T03573   .a 1311 to 1765 453 to 1       453/455
(99 %)
8 diff
(98.3 %id)
DB562291 hypothalamus .a 1312 to 1758 1 to 450     Submitted on the opposite strand 450/452
(99 %)
11 diff
(97.6 %id)
AI167360 senescent fibroblast .a 1313 to 1767 458 to 4   tiling clone,   455/458
(99 %)
0 diff
(100 %id)
AW474703 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1313 to 1767 457 to 3       455/457
(99 %)
0 diff
(100 %id)
AI620045 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1319 to 1765 440 to 1       440/440
(100 %)
11 diff
(97.5 %id)
DB517915 testis .a 1320 to 1758 1 to 439     Submitted on the opposite strand 439/439
(100 %)
0 diff
(100 %id)
AI183426 placenta .a 1330 to 1767 441 to 4       438/441
(99 %)
5 diff
(98.9 %id)
AI951112 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 1332 to 1760 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
W45457 Pancreas, pancreatic islet .a 1366 to 1760 407 to 13   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 395/396
(99 %)
0 diff
(100 %id)
AW504896 lymph .a 1372 to 1758 425 to 39   AAA Submitted on the opposite strand 387/389
(99 %)
0 diff
(100 %id)
AI476386 colon, moderately-differentiated adenocarcinoma .a 1374 to 1758 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
AI440243 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1375 to 1761 388 to 1       388/388
(100 %)
4 diff
(99.0 %id)
AA814344 germinal center B cell .a 1376 to 1765 411 to 27   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 385/385
(100 %)
5 diff
(98.8 %id)
F35902 pectoral muscle (after mastectomy) .a 1376 to 1679 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
BP306539   .a 1379 to 1760 1 to 382   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 382/382
(100 %)
3 diff
(99.3 %id)
AI925462 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1389 to 1767 385 to 8       378/385
(98 %)
0 diff
(100 %id)
N21300 melanocyte .a 1413 to 1768 362 to 2   fully sequenced,   361/362
(99 %)
9 diff
(97.6 %id)
AA092862   .a 1414 to 1744 32 to 358   AAA   327/369
(88 %)
14 diff
(96.3 %id)
AA084595   .a 1415 to 1767 358 to 5       354/368
(96 %)
0 diff
(100 %id)
BE876652 large cell carcinoma, undifferentiated, lung .a 1417 to 1767 1 to 351   AAA   351/687
(51 %)
8 diff
(98.9 %id)
AI917053 Kidney, renal cell tumor .a 1439 to 1760 354 to 33   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 322/322
(100 %)
13 diff
(96.0 %id)
AI300208 placenta .a 1458 to 1761 305 to 3       303/305
(99 %)
0 diff
(100 %id)
CF528989 placenta .a 1498 to 1765 285 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 268/268
(100 %)
3 diff
(98.9 %id)
BG187623   .a 1511 to 1761 71 to 321       251/323
(77 %)
3 diff
(99.1 %id)
AW242238 adenocarcinoma, Pancreas .a 1516 to 1761 250 to 2       249/250
(99 %)
0 diff
(100 %id)
AI916214 colon, colon tumor, RER+ .a 1518 to 1758 242 to 2       241/242
(99 %)
0 diff
(100 %id)
BM469466 lymph, lymphoma, cell line .a 1532 to 1760 1 to 230   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 230/230
(100 %)
2 diff
(99.2 %id)
AI539472 pooled .a 1555 to 1767 214 to 2       213/370
(57 %)
0 diff
(100 %id)
AI689540 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1585 to 1765 222 to 42   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 181/181
(100 %)
4 diff
(97.8 %id)
AK095007 hippocampus .b-u 1 to 2723 2 to 2724 exact tiling clone, available from FLJ,   2724/2724
(100 %)
3 diff
(99.9 %id)
DA300052 hippocampus .b-u 1 to 576 2 to 577 exact capped   576/576
(100 %)
1 diff
(99.9 %id)
AA654966   .b-u 1151 to 1531 8 to 388       381/388
(98 %)
6 diff
(98.5 %id)
DB307984 hippocampus .b-u 2515 to 2723 209 to 1       209/209
(100 %)
1 diff
(99.6 %id)
BP301626   .c 1 to 581 1 to 580 G7V R9G E11S Q12S R13A ... tiling clone,   580/580
(100 %)
3 diff
(99.5 %id)
BF364126 nervous_normal .c 124 to 464 19 to 356       338/356
(94 %)
6 diff
(98.4 %id)
BP296600   .c 189 to 645 1 to 457   tiling clone, AAA   457/457
(100 %)
1 diff
(99.8 %id)
FN060611 breast carcinoma .c 378 to 482 105 to 1     Submitted on the opposite strand 105/105
(100 %)
0 diff
(100 %id)
AL701506 human skeletal muscle .d-u 1 to 490 2 to 491 exact tiling clone,   491/491
(100 %)
0 diff
(100 %id)
DB092714 testis .d-u 8 to 565 2 to 561 R47X Q48A R49A L50P L51S ... capped   560/560
(100 %)
3 diff
(99.5 %id)
DB139185 thymus .d-u 10 to 507 2 to 500 exact capped   499/499
(100 %)
2 diff
(99.6 %id)
DB237882 trachea .d-u 16 to 619 2 to 605 F35L tiling clone, capped   604/604
(100 %)
1 diff
(99.9 %id)
DB287459 uterus .d-u 16 to 572 2 to 558 exact capped   557/557
(100 %)
0 diff
(100 %id)
BX498819 Liver .d-u 19 to 399 1 to 381 exact     381/381
(100 %)
1 diff
(99.8 %id)
DA335006 hippocampus .d-u 22 to 602 2 to 582 exact capped   581/581
(100 %)
1 diff
(99.9 %id)
BP227370   .e-u 1 to 569 1 to 568 exact tiling clone,   568/582
(97 %)
1 diff
(99.9 %id)
CD367185 Alveolar Macrophage, lung Gene MRPL44, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CD385497 embryonic trophoblasts, made from WA01 stemcells Gene MRPL44, variant not shown         This clone was ignored    
BP338300 Spleen Gene MRPL44, variant not shown         Suspected internal deletion, this clone was ignored    
AA805934 germinal center B cell Gene MRPL44, variant not shown       AAA This clone was ignored    
AI244503 Kidney Gene MRPL44, variant not shown         This clone was ignored    
TI_227712680   Gene MRPL44, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d-u, .e-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI